According to the website of the State Drug Administration today, the State Drug Administration has conditionally approved the new crown vaccine registration applications of Cansino Biotech Co., Ltd. and Sinopharm Zhongsheng Wuhan Company. It is reported that the team of Academician Chen Wei of the Academy of Military Medicine of the Academy of Military Sciences and Kansino Biosciences jointly developed a recombinant new coronavirus vaccine (type 5 adenovirus vector). According to the news, the vaccine only needs one shot.

new crown vaccine

According to the website of the National Medical Products Administration, the vaccine is the first domestically-made adenovirus vector new coronavirus vaccine approved and is suitable for preventing the disease (COVID-19) caused by the new coronavirus infection.

new crown vaccine

According to the relevant provisions of the "Vaccine Administration Law" and "Drug Administration Law", the State Food and Drug Administration conducts emergency review and approval in accordance with the special drug approval procedures, and approves the application for listing registration with conditions. The State Food and Drug Administration requires the vaccine marketing license holder to continue to carry out relevant research work, complete the conditional requirements, and submit follow-up research results in a timely manner.

标签: new crown vaccine, Chinese Academician


阿里云优惠主机

添加新评论

免责声明
本博客部分内容来自于互联网,不代表作者的观点和立场,如若侵犯到您的权益,请联系[email protected]。我们会在24小时内进行删除。